| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 7.44e-08 | 3 | 85 | 3 | GO:0035979 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 7.40e-07 | 5 | 85 | 3 | GO:0141003 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 4.85e-05 | 17 | 85 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | microtubule binding | 5.03e-05 | 308 | 85 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 5.36e-05 | 3 | 85 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.80e-04 | 26 | 85 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | histone kinase activity | 2.26e-04 | 28 | 85 | 3 | GO:0035173 | |
| GeneOntologyMolecularFunction | chromatin insulator sequence binding | 3.71e-04 | 7 | 85 | 2 | GO:0043035 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.48e-04 | 230 | 85 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | tubulin binding | 4.75e-04 | 428 | 85 | 8 | GO:0015631 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 7.06e-04 | 41 | 85 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 9.61e-04 | 11 | 85 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 1.05e-03 | 372 | 85 | 7 | GO:0061630 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.15e-03 | 12 | 85 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.54e-03 | 398 | 85 | 7 | GO:0061659 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.58e-03 | 14 | 85 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.62e-03 | 118 | 85 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 2.07e-03 | 16 | 85 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NCKIPSD KCNMA1 APC TRIM63 TRIM54 CDK5RAP2 KIF5B KIF5C SKA3 MYO15A CAMSAP1 KIF3A | 2.33e-03 | 1099 | 85 | 12 | GO:0008092 |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.56e-03 | 323 | 85 | 6 | GO:1901681 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 2.24e-07 | 217 | 83 | 9 | GO:0000075 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 4.84e-07 | 311 | 83 | 10 | GO:1901988 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 4.85e-07 | 73 | 83 | 6 | GO:0051784 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | GBF1 INCENP PIK3CD APC CDK5RAP2 UNC13C KIF5B ATM KIF5C SKA3 KIF3A KNL1 | 1.84e-06 | 546 | 83 | 12 | GO:0051656 |
| GeneOntologyBiologicalProcess | mitotic spindle assembly checkpoint signaling | 1.90e-06 | 51 | 83 | 5 | GO:0007094 | |
| GeneOntologyBiologicalProcess | spindle assembly checkpoint signaling | 1.90e-06 | 51 | 83 | 5 | GO:0071173 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 1.91e-06 | 362 | 83 | 10 | GO:0010948 | |
| GeneOntologyBiologicalProcess | anterograde dendritic transport of neurotransmitter receptor complex | 2.17e-06 | 7 | 83 | 3 | GO:0098971 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic metaphase/anaphase transition | 2.30e-06 | 53 | 83 | 5 | GO:0045841 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid segregation | 2.30e-06 | 53 | 83 | 5 | GO:0033048 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid segregation | 2.30e-06 | 53 | 83 | 5 | GO:0033046 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid separation | 2.30e-06 | 53 | 83 | 5 | GO:2000816 | |
| GeneOntologyBiologicalProcess | mitotic spindle checkpoint signaling | 2.30e-06 | 53 | 83 | 5 | GO:0071174 | |
| GeneOntologyBiologicalProcess | negative regulation of metaphase/anaphase transition of cell cycle | 2.77e-06 | 55 | 83 | 5 | GO:1902100 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome separation | 2.77e-06 | 55 | 83 | 5 | GO:1905819 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 2.83e-06 | 219 | 83 | 8 | GO:1901991 | |
| GeneOntologyBiologicalProcess | spindle checkpoint signaling | 3.32e-06 | 57 | 83 | 5 | GO:0031577 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome segregation | 3.32e-06 | 57 | 83 | 5 | GO:0051985 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 4.24e-06 | 163 | 83 | 7 | GO:0007093 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 4.29e-06 | 60 | 83 | 5 | GO:0033047 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 5.91e-06 | 64 | 83 | 5 | GO:0045839 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 5.91e-06 | 64 | 83 | 5 | GO:0010965 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | KLF11 ATR INCENP PPP2R3B APC CDK5RAP2 PRKDC ATM TP53BP1 ZFY KNL1 | 6.86e-06 | 516 | 83 | 11 | GO:1901987 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 7.42e-06 | 67 | 83 | 5 | GO:0051306 | |
| GeneOntologyBiologicalProcess | axo-dendritic protein transport | 1.01e-05 | 11 | 83 | 3 | GO:0099640 | |
| GeneOntologyBiologicalProcess | anterograde dendritic transport | 1.35e-05 | 12 | 83 | 3 | GO:0098937 | |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 1.60e-05 | 2 | 83 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 1.60e-05 | 2 | 83 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 1.60e-05 | 2 | 83 | 2 | GO:1904882 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 1.67e-05 | 79 | 83 | 5 | GO:1905818 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 1.69e-05 | 464 | 83 | 10 | GO:0045786 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 1.80e-05 | 282 | 83 | 8 | GO:0045930 | |
| GeneOntologyBiologicalProcess | organelle localization | GBF1 INCENP PIK3CD APC CDK5RAP2 UNC13C KIF5B ATM KIF5C SKA3 KIF3A KNL1 | 2.36e-05 | 703 | 83 | 12 | GO:0051640 |
| GeneOntologyBiologicalProcess | chromosome separation | 2.82e-05 | 88 | 83 | 5 | GO:0051304 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 3.42e-05 | 402 | 83 | 9 | GO:1901990 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 4.07e-05 | 95 | 83 | 5 | GO:0030071 | |
| GeneOntologyBiologicalProcess | microtubule-based protein transport | 4.10e-05 | 17 | 83 | 3 | GO:0099118 | |
| GeneOntologyBiologicalProcess | protein transport along microtubule | 4.10e-05 | 17 | 83 | 3 | GO:0098840 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | KLF11 ATR INCENP PPP2R3B APC CDK5RAP2 PRKDC ATM TP53BP1 ZFY KNL1 | 4.16e-05 | 627 | 83 | 11 | GO:0044770 |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 4.73e-05 | 98 | 83 | 5 | GO:1902099 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization to telomere | 4.79e-05 | 3 | 83 | 2 | GO:0097694 | |
| GeneOntologyBiologicalProcess | establishment of protein-containing complex localization to telomere | 4.79e-05 | 3 | 83 | 2 | GO:0097695 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 5.21e-05 | 100 | 83 | 5 | GO:0007091 | |
| GeneOntologyBiologicalProcess | dendritic transport | 5.81e-05 | 19 | 83 | 3 | GO:0098935 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 6.00e-05 | 103 | 83 | 5 | GO:0044784 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 6.84e-05 | 172 | 83 | 6 | GO:0051783 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 7.20e-05 | 107 | 83 | 5 | GO:2001251 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 7.53e-05 | 108 | 83 | 5 | GO:0031110 | |
| GeneOntologyBiologicalProcess | attachment of spindle microtubules to kinetochore | 7.63e-05 | 56 | 83 | 4 | GO:0008608 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 8.57e-05 | 111 | 83 | 5 | GO:0033045 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 9.55e-05 | 4 | 83 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle checkpoint | 1.05e-04 | 23 | 83 | 3 | GO:1903504 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle spindle assembly checkpoint | 1.05e-04 | 23 | 83 | 3 | GO:0090266 | |
| GeneOntologyBiologicalProcess | thymus development | 1.07e-04 | 61 | 83 | 4 | GO:0048538 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 1.34e-04 | 594 | 83 | 10 | GO:0007346 | |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 1.34e-04 | 122 | 83 | 5 | GO:0051303 | |
| GeneOntologyBiologicalProcess | regulation of spindle checkpoint | 1.53e-04 | 26 | 83 | 3 | GO:0090231 | |
| GeneOntologyBiologicalProcess | chromosome localization | 1.80e-04 | 130 | 83 | 5 | GO:0050000 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 2.06e-04 | 509 | 83 | 9 | GO:0044772 | |
| GeneOntologyBiologicalProcess | regulation of mitotic nuclear division | 2.08e-04 | 134 | 83 | 5 | GO:0007088 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 2.15e-04 | 212 | 83 | 6 | GO:0000070 | |
| GeneOntologyBiologicalProcess | nuclear division | 2.15e-04 | 512 | 83 | 9 | GO:0000280 | |
| GeneOntologyBiologicalProcess | plus-end-directed vesicle transport along microtubule | 2.37e-04 | 6 | 83 | 2 | GO:0072383 | |
| GeneOntologyBiologicalProcess | telomerase holoenzyme complex assembly | 2.37e-04 | 6 | 83 | 2 | GO:1905323 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 2.46e-04 | 139 | 83 | 5 | GO:0051983 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 2.92e-04 | 421 | 83 | 8 | GO:0010639 | |
| GeneOntologyBiologicalProcess | plus-end-directed organelle transport along microtubule | 3.32e-04 | 7 | 83 | 2 | GO:0072386 | |
| GeneOntologyBiologicalProcess | cellular extravasation | 3.85e-04 | 85 | 83 | 4 | GO:0045123 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 4.17e-04 | 240 | 83 | 6 | GO:0140013 | |
| GeneOntologyBiologicalProcess | organelle fission | 4.77e-04 | 571 | 83 | 9 | GO:0048285 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 4.79e-04 | 38 | 83 | 3 | GO:0007026 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | KLF11 ATR INCENP PPP2R3B APC CDK5RAP2 PRKDC ATM TP53BP1 ZFY KNL1 | 5.59e-04 | 845 | 83 | 11 | GO:0010564 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 5.62e-04 | 254 | 83 | 6 | GO:0000819 | |
| GeneOntologyBiologicalProcess | anterograde axonal protein transport | 5.65e-04 | 9 | 83 | 2 | GO:0099641 | |
| GeneOntologyBiologicalProcess | cell cycle process | KLF11 ATR INCENP PPP2R3B APC CDK5RAP2 PRKDC ATM SKA3 RSPO1 TP53BP1 KIF3A ZFY KNL1 FANCA | 5.73e-04 | 1441 | 83 | 15 | GO:0022402 |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 5.87e-04 | 168 | 83 | 5 | GO:0031109 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 6.44e-04 | 42 | 83 | 3 | GO:0031114 | |
| GeneOntologyBiologicalProcess | negative regulation of G1/S transition of mitotic cell cycle | 6.61e-04 | 98 | 83 | 4 | GO:2000134 | |
| GeneOntologyBiologicalProcess | regulation of germ cell proliferation | 7.05e-04 | 10 | 83 | 2 | GO:1905936 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 7.16e-04 | 266 | 83 | 6 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 7.25e-04 | 176 | 83 | 5 | GO:0070507 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 7.44e-04 | 268 | 83 | 6 | GO:1903046 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle checkpoint signaling | 8.59e-04 | 11 | 83 | 2 | GO:0033313 | |
| GeneOntologyBiologicalProcess | cellular response to X-ray | 8.59e-04 | 11 | 83 | 2 | GO:0071481 | |
| GeneOntologyBiologicalProcess | protein localization to presynapse | 8.59e-04 | 11 | 83 | 2 | GO:1905383 | |
| GeneOntologyBiologicalProcess | metaphase chromosome alignment | 9.18e-04 | 107 | 83 | 4 | GO:0051310 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle G1/S phase transition | 9.84e-04 | 109 | 83 | 4 | GO:1902807 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 1.14e-03 | 51 | 83 | 3 | GO:0031111 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 1.18e-03 | 293 | 83 | 6 | GO:0032886 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle checkpoint | 1.20e-03 | 52 | 83 | 3 | GO:1901976 | |
| GeneOntologyBiologicalProcess | negative regulation of meiotic nuclear division | 1.21e-03 | 13 | 83 | 2 | GO:0045835 | |
| GeneOntologyBiologicalProcess | negative regulation of motor neuron apoptotic process | 1.21e-03 | 13 | 83 | 2 | GO:2000672 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 1.21e-03 | 13 | 83 | 2 | GO:0038133 | |
| GeneOntologyBiologicalProcess | positive regulation of spindle checkpoint | 1.21e-03 | 13 | 83 | 2 | GO:0090232 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 1.41e-03 | 14 | 83 | 2 | GO:0038129 | |
| GeneOntologyBiologicalProcess | anterograde axonal transport | 1.42e-03 | 55 | 83 | 3 | GO:0008089 | |
| GeneOntologyBiologicalProcess | response to gamma radiation | 1.49e-03 | 56 | 83 | 3 | GO:0010332 | |
| GeneOntologyBiologicalProcess | germ cell proliferation | 1.62e-03 | 15 | 83 | 2 | GO:0036093 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 1.69e-03 | 213 | 83 | 5 | GO:2000045 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 1.73e-03 | 316 | 83 | 6 | GO:0140014 | |
| GeneOntologyCellularComponent | microtubule | INCENP TRIM55 APC TRIM63 TRIM54 CDK5RAP2 KIF5B KIF5C SKA3 CAMSAP1 KIF3A | 9.24e-06 | 533 | 84 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | DNA repair complex | 1.05e-04 | 23 | 84 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | supramolecular fiber | FBN1 INCENP EFEMP2 NCKIPSD TRIM55 APC TRIM63 TRIM54 CDK5RAP2 KIF5B KIF5C SKA3 CAMSAP1 KIF3A | 2.38e-04 | 1179 | 84 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | INCENP NCKIPSD TRIM55 APC TRIM63 TRIM54 CDK5RAP2 KIF5B KIF5C SKA3 CAMSAP1 KIF3A | 2.43e-04 | 899 | 84 | 12 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular polymer | FBN1 INCENP EFEMP2 NCKIPSD TRIM55 APC TRIM63 TRIM54 CDK5RAP2 KIF5B KIF5C SKA3 CAMSAP1 KIF3A | 2.55e-04 | 1187 | 84 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | chromosomal region | 2.90e-04 | 421 | 84 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | microtubule associated complex | 4.82e-04 | 161 | 84 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | aggresome | 5.55e-04 | 40 | 84 | 3 | GO:0016235 | |
| GeneOntologyCellularComponent | axonal growth cone | 7.86e-04 | 45 | 84 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | kinetochore | 8.18e-04 | 181 | 84 | 5 | GO:0000776 | |
| GeneOntologyCellularComponent | cell body fiber | 8.57e-04 | 11 | 84 | 2 | GO:0070852 | |
| GeneOntologyCellularComponent | kinesin complex | 1.01e-03 | 49 | 84 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 1.09e-03 | 193 | 84 | 5 | GO:0000779 | |
| GeneOntologyCellularComponent | microfibril | 1.21e-03 | 13 | 84 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | ciliary rootlet | 1.85e-03 | 16 | 84 | 2 | GO:0035253 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 2.35e-03 | 230 | 84 | 5 | GO:0019898 | |
| GeneOntologyCellularComponent | axon cytoplasm | 2.60e-03 | 68 | 84 | 3 | GO:1904115 | |
| HumanPheno | Prenatal growth deficiency | RAF1 KLF11 FBN1 ATR IARS1 PI4KA EFEMP2 DEF6 LEMD2 SCUBE3 PRKDC KIF5C FANCA | 2.28e-05 | 631 | 30 | 13 | HP:0001515 |
| HumanPheno | Intrauterine growth retardation | RAF1 KLF11 FBN1 ATR IARS1 PI4KA EFEMP2 DEF6 LEMD2 SCUBE3 PRKDC KIF5C FANCA | 2.28e-05 | 631 | 30 | 13 | HP:0001511 |
| MousePheno | increased central memory CD4-positive, alpha-beta T cell number | 5.36e-06 | 24 | 69 | 4 | MP:0010841 | |
| MousePheno | decreased oocyte number | 7.13e-06 | 95 | 69 | 6 | MP:0005431 | |
| MousePheno | abnormal oocyte number | 7.58e-06 | 96 | 69 | 6 | MP:0020152 | |
| MousePheno | spontaneous chromosome breakage | 1.18e-05 | 29 | 69 | 4 | MP:0004029 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell number | 1.35e-05 | 30 | 69 | 4 | MP:0012771 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell morphology | 1.35e-05 | 30 | 69 | 4 | MP:0010840 | |
| MousePheno | decreased mature ovarian follicle number | 2.93e-05 | 73 | 69 | 5 | MP:0002682 | |
| MousePheno | abnormal mature ovarian follicle morphology | 4.04e-05 | 78 | 69 | 5 | MP:0009364 | |
| MousePheno | abnormal oocyte morphology | 5.97e-05 | 138 | 69 | 6 | MP:0001125 | |
| MousePheno | increased cellular sensitivity to alkylating agents | 6.16e-05 | 16 | 69 | 3 | MP:0008402 | |
| MousePheno | abnormal ovarian follicle number | 6.18e-05 | 203 | 69 | 7 | MP:0008871 | |
| MousePheno | abnormal female germ cell morphology | 9.49e-05 | 150 | 69 | 6 | MP:0006361 | |
| MousePheno | abnormal heart ventricle wall morphology | 1.00e-04 | 296 | 69 | 8 | MP:0031532 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | RAF1 ERBB3 FBN1 EFEMP2 UBR4 LEMD2 APC KIF5B CABIN1 ZFX KIF3A ZFY | 1.44e-04 | 700 | 69 | 12 | MP:0011098 |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell morphology | 1.53e-04 | 55 | 69 | 4 | MP:0010834 | |
| MousePheno | abnormal ovarian follicle morphology | 1.99e-04 | 245 | 69 | 7 | MP:0001131 | |
| MousePheno | increased CD4-positive, alpha-beta memory T cell number | 2.02e-04 | 59 | 69 | 4 | MP:0010835 | |
| MousePheno | abnormal apoptosis | RAF1 ERBB3 DSC2 ATR PI4KA UCHL3 EFEMP2 BACH1 DEF6 LEMD2 KCNMA1 APC RBM5 TRIM54 CDK5RAP2 PRKDC FANCA | 2.36e-04 | 1353 | 69 | 17 | MP:0001648 |
| MousePheno | ascending aorta aneurysm | 2.38e-04 | 5 | 69 | 2 | MP:0010661 | |
| MousePheno | chromosome breakage | 2.44e-04 | 62 | 69 | 4 | MP:0004028 | |
| MousePheno | induced chromosome breakage | 2.45e-04 | 25 | 69 | 3 | MP:0004030 | |
| MousePheno | abnormal programmed cell death | RAF1 ERBB3 DSC2 ATR PI4KA UCHL3 EFEMP2 BACH1 DEF6 LEMD2 KCNMA1 APC RBM5 TRIM54 CDK5RAP2 PRKDC FANCA | 2.51e-04 | 1360 | 69 | 17 | MP:0014355 |
| MousePheno | increased cellular sensitivity to DNA damaging agents | 2.76e-04 | 26 | 69 | 3 | MP:0014040 | |
| MousePheno | increased sensitivity to induced cell death | 2.89e-04 | 184 | 69 | 6 | MP:0008943 | |
| MousePheno | abnormal oogenesis | 3.06e-04 | 186 | 69 | 6 | MP:0001931 | |
| MousePheno | decreased splenocyte number | 3.45e-04 | 28 | 69 | 3 | MP:0009339 | |
| MousePheno | thoracic aorta aneurysm | 3.56e-04 | 6 | 69 | 2 | MP:0010658 | |
| MousePheno | increased memory T cell number | 3.62e-04 | 124 | 69 | 5 | MP:0008049 | |
| MousePheno | increased cell death | RAF1 ERBB3 DSC2 ATR PI4KA UCHL3 LEMD2 KCNMA1 APC RBM5 TRIM54 CDK5RAP2 PRKDC FANCA | 3.84e-04 | 1019 | 69 | 14 | MP:0012556 |
| MousePheno | cardiac hypertrophy | 4.05e-04 | 196 | 69 | 6 | MP:0001625 | |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell number | 4.82e-04 | 74 | 69 | 4 | MP:0012769 | |
| MousePheno | hypochlorhydria | 4.96e-04 | 7 | 69 | 2 | MP:0008001 | |
| MousePheno | abnormal female reproductive gland morphology | 5.18e-04 | 475 | 69 | 9 | MP:0013324 | |
| MousePheno | increased gland tumor incidence | 6.10e-04 | 139 | 69 | 5 | MP:0010288 | |
| MousePheno | abnormal cutaneous elastic fiber morphology | 6.60e-04 | 8 | 69 | 2 | MP:0008418 | |
| MousePheno | increased mortality induced by gamma-irradiation | 7.93e-04 | 37 | 69 | 3 | MP:0001658 | |
| MousePheno | increased aorta wall thickness | 8.45e-04 | 9 | 69 | 2 | MP:0010996 | |
| MousePheno | abnormal aorta bulb morphology | 8.45e-04 | 9 | 69 | 2 | MP:0011572 | |
| MousePheno | increased quadriceps weight | 8.45e-04 | 9 | 69 | 2 | MP:0010226 | |
| Domain | PI3/4_kinase_CS | 4.45e-09 | 15 | 83 | 5 | IPR018936 | |
| Domain | - | 6.45e-09 | 16 | 83 | 5 | 1.10.1070.11 | |
| Domain | PI3Kc | 6.45e-09 | 16 | 83 | 5 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 1.26e-08 | 18 | 83 | 5 | IPR000403 | |
| Domain | PI3_PI4_kinase | 1.26e-08 | 18 | 83 | 5 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.26e-08 | 18 | 83 | 5 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 1.26e-08 | 18 | 83 | 5 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.26e-08 | 18 | 83 | 5 | PS00916 | |
| Domain | Znf-RING_LisH | 3.86e-07 | 34 | 83 | 5 | IPR027370 | |
| Domain | zf-RING_UBOX | 3.86e-07 | 34 | 83 | 5 | PF13445 | |
| Domain | FATC | 8.41e-07 | 5 | 83 | 3 | PF02260 | |
| Domain | FAT | 1.68e-06 | 6 | 83 | 3 | PS51189 | |
| Domain | FATC | 1.68e-06 | 6 | 83 | 3 | PS51190 | |
| Domain | FAT | 1.68e-06 | 6 | 83 | 3 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.68e-06 | 6 | 83 | 3 | IPR003151 | |
| Domain | FATC_dom | 1.68e-06 | 6 | 83 | 3 | IPR003152 | |
| Domain | PIK_FAT | 1.68e-06 | 6 | 83 | 3 | IPR014009 | |
| Domain | FATC | 1.68e-06 | 6 | 83 | 3 | SM01343 | |
| Domain | ARM-type_fold | 2.56e-06 | 339 | 83 | 10 | IPR016024 | |
| Domain | cEGF | 5.03e-06 | 26 | 83 | 4 | IPR026823 | |
| Domain | cEGF | 5.03e-06 | 26 | 83 | 4 | PF12662 | |
| Domain | Growth_fac_rcpt_ | 6.05e-06 | 156 | 83 | 7 | IPR009030 | |
| Domain | BBOX | 1.38e-05 | 69 | 83 | 5 | SM00336 | |
| Domain | - | 1.59e-05 | 71 | 83 | 5 | 4.10.45.10 | |
| Domain | zf-B_box | 1.70e-05 | 72 | 83 | 5 | PF00643 | |
| Domain | COS_domain | 1.81e-05 | 12 | 83 | 3 | IPR017903 | |
| Domain | COS | 1.81e-05 | 12 | 83 | 3 | PS51262 | |
| Domain | ZF_BBOX | 2.84e-05 | 80 | 83 | 5 | PS50119 | |
| Domain | Znf_B-box | 3.02e-05 | 81 | 83 | 5 | IPR000315 | |
| Domain | Zfx_Zfy_act | 5.84e-05 | 3 | 83 | 2 | PF04704 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 5.84e-05 | 3 | 83 | 2 | IPR006794 | |
| Domain | ZF_UBR | 4.04e-04 | 7 | 83 | 2 | PS51157 | |
| Domain | zf-UBR | 4.04e-04 | 7 | 83 | 2 | PF02207 | |
| Domain | Znf_UBR | 4.04e-04 | 7 | 83 | 2 | IPR003126 | |
| Domain | ZnF_UBR1 | 4.04e-04 | 7 | 83 | 2 | SM00396 | |
| Domain | zf-C3HC4 | 4.76e-04 | 223 | 83 | 6 | PF00097 | |
| Domain | EGF_CA | 5.84e-04 | 86 | 83 | 4 | PF07645 | |
| Domain | PI3Ka | 6.88e-04 | 9 | 83 | 2 | PF00613 | |
| Domain | - | 6.88e-04 | 9 | 83 | 2 | 1.25.40.70 | |
| Domain | PI3Ka | 6.88e-04 | 9 | 83 | 2 | SM00145 | |
| Domain | Kinesin_motor_CS | 7.99e-04 | 41 | 83 | 3 | IPR019821 | |
| Domain | Znf_RING_CS | 7.99e-04 | 163 | 83 | 5 | IPR017907 | |
| Domain | - | 8.55e-04 | 449 | 83 | 8 | 3.30.40.10 | |
| Domain | PIK_HELICAL | 8.58e-04 | 10 | 83 | 2 | PS51545 | |
| Domain | PI_Kinase | 8.58e-04 | 10 | 83 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 8.58e-04 | 10 | 83 | 2 | IPR001263 | |
| Domain | EGF_Ca-bd_CS | 9.18e-04 | 97 | 83 | 4 | IPR018097 | |
| Domain | Kinesin-like_fam | 9.19e-04 | 43 | 83 | 3 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 9.83e-04 | 44 | 83 | 3 | PS00411 | |
| Domain | - | 9.83e-04 | 44 | 83 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 9.83e-04 | 44 | 83 | 3 | IPR001752 | |
| Domain | Kinesin | 9.83e-04 | 44 | 83 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 9.83e-04 | 44 | 83 | 3 | PS50067 | |
| Domain | KISc | 9.83e-04 | 44 | 83 | 3 | SM00129 | |
| Domain | Znf_RING/FYVE/PHD | 9.86e-04 | 459 | 83 | 8 | IPR013083 | |
| Domain | EGF_CA | 9.91e-04 | 99 | 83 | 4 | PS01187 | |
| Domain | Znf_C3HC4_RING-type | 1.02e-03 | 172 | 83 | 5 | IPR018957 | |
| Domain | ASX_HYDROXYL | 1.03e-03 | 100 | 83 | 4 | PS00010 | |
| Domain | HEAT | 1.27e-03 | 48 | 83 | 3 | PF02985 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.28e-03 | 106 | 83 | 4 | IPR000152 | |
| Domain | ZF_RING_1 | 1.88e-03 | 291 | 83 | 6 | PS00518 | |
| Domain | ZF_RING_2 | 2.12e-03 | 298 | 83 | 6 | PS50089 | |
| Domain | EGF_CA | 2.14e-03 | 122 | 83 | 4 | SM00179 | |
| Domain | HEAT | 2.19e-03 | 58 | 83 | 3 | IPR000357 | |
| Domain | EGF-like_Ca-bd_dom | 2.27e-03 | 124 | 83 | 4 | IPR001881 | |
| Domain | Kinase-like_dom | 2.80e-03 | 542 | 83 | 8 | IPR011009 | |
| Domain | Furin_repeat | 2.85e-03 | 18 | 83 | 2 | IPR006212 | |
| Domain | FU | 2.85e-03 | 18 | 83 | 2 | SM00261 | |
| Domain | Znf_RING | 3.30e-03 | 326 | 83 | 6 | IPR001841 | |
| Domain | HEAT_REPEAT | 3.74e-03 | 70 | 83 | 3 | PS50077 | |
| Domain | EGF_3 | 3.96e-03 | 235 | 83 | 5 | PS50026 | |
| Domain | EGF | 3.96e-03 | 235 | 83 | 5 | SM00181 | |
| Pathway | PID_BARD1_PATHWAY | 1.21e-05 | 29 | 70 | 4 | M258 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 4.99e-05 | 81 | 70 | 5 | M39490 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 8.46e-05 | 47 | 70 | 4 | M39518 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.18e-04 | 301 | 70 | 8 | MM15983 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 1.57e-04 | 55 | 70 | 4 | M39598 | |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 1.69e-04 | 22 | 70 | 3 | M9703 | |
| Pathway | BIOCARTA_G2_PATHWAY | 2.20e-04 | 24 | 70 | 3 | M8560 | |
| Pubmed | Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. | 1.41e-08 | 3 | 85 | 3 | 9766667 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 18451257 | ||
| Pubmed | DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells. | 1.41e-08 | 3 | 85 | 3 | 27733644 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 31601897 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 31164689 | ||
| Pubmed | Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. | 1.41e-08 | 3 | 85 | 3 | 19444312 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 15998665 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 15539948 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 19450527 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 11243782 | ||
| Pubmed | Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. | 1.40e-07 | 5 | 85 | 3 | 19596237 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 16540648 | ||
| Pubmed | ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. | 1.40e-07 | 5 | 85 | 3 | 17599403 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 20231360 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 25264618 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 29976923 | ||
| Pubmed | The complexity of p53 modulation: emerging patterns from divergent signals. | 2.80e-07 | 6 | 85 | 3 | 9765199 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 34702928 | ||
| Pubmed | Telomere protection by TPP1/POT1 requires tethering to TIN2. | 4.90e-07 | 7 | 85 | 3 | 22099311 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 17171639 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 11927605 | ||
| Pubmed | BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer. | 4.90e-07 | 7 | 85 | 3 | 16872911 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 10673501 | ||
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 6.50e-07 | 28 | 85 | 4 | 35227662 | |
| Pubmed | Gene knockouts that cause female infertility: search for novel contraceptive targets. | 6.50e-07 | 28 | 85 | 4 | 15970507 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 15456891 | ||
| Pubmed | Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail. | 7.82e-07 | 8 | 85 | 3 | 22184063 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 20810650 | ||
| Pubmed | 9.94e-07 | 31 | 85 | 4 | 19690177 | ||
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 21185285 | ||
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 1.67e-06 | 10 | 85 | 3 | 18160036 | |
| Pubmed | 1.84e-06 | 36 | 85 | 4 | 22626734 | ||
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 2.29e-06 | 11 | 85 | 3 | 20427287 | |
| Pubmed | Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. | 2.29e-06 | 11 | 85 | 3 | 15758953 | |
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 11551930 | ||
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 11709713 | ||
| Pubmed | Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. | 2.29e-06 | 11 | 85 | 3 | 16400328 | |
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 15364958 | ||
| Pubmed | ERBB3 ZBTB38 FBN1 EFEMP2 UBR4 BACH1 APC PRKDC ATM CAMK1 KIF5C CABIN1 LRP1B KIF3A | 2.70e-06 | 1285 | 85 | 14 | 35914814 | |
| Pubmed | 2.73e-06 | 89 | 85 | 5 | 18950845 | ||
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 15854902 | ||
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 15149599 | ||
| Pubmed | LRCH2 PI4KA UBR4 KCNMA1 APC CDK5RAP2 KIF5B KIF5C CAMSAP1 CABIN1 TP53BP1 KIF3A | 3.90e-06 | 963 | 85 | 12 | 28671696 | |
| Pubmed | 5.35e-06 | 276 | 85 | 7 | 28319085 | ||
| Pubmed | Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. | 5.90e-06 | 2 | 85 | 2 | 19285939 | |
| Pubmed | Expression variations of DNA damage response genes ATM and ATR in blood cancer patients. | 5.90e-06 | 2 | 85 | 2 | 37338595 | |
| Pubmed | 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. | 5.90e-06 | 2 | 85 | 2 | 27613518 | |
| Pubmed | ATM and 53BP1 regulate alternative end joining-mediated V(D)J recombination. | 5.90e-06 | 2 | 85 | 2 | 39083600 | |
| Pubmed | Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis. | 5.90e-06 | 2 | 85 | 2 | 11231155 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28851706 | ||
| Pubmed | Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. | 5.90e-06 | 2 | 85 | 2 | 10464290 | |
| Pubmed | Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM. | 5.90e-06 | 2 | 85 | 2 | 27939942 | |
| Pubmed | Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM). | 5.90e-06 | 2 | 85 | 2 | 34151669 | |
| Pubmed | Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene. | 5.90e-06 | 2 | 85 | 2 | 1691708 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8188262 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21487018 | ||
| Pubmed | DNA structure-specific priming of ATR activation by DNA-PKcs. | 5.90e-06 | 2 | 85 | 2 | 23897887 | |
| Pubmed | Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome. | 5.90e-06 | 2 | 85 | 2 | 16213462 | |
| Pubmed | Mapping the human ZFX locus to Xp21.3 by in situ hybridization. | 5.90e-06 | 2 | 85 | 2 | 2497060 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27442013 | ||
| Pubmed | Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. | 5.90e-06 | 2 | 85 | 2 | 26057167 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24726882 | ||
| Pubmed | Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY. | 5.90e-06 | 2 | 85 | 2 | 2041734 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8318216 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26061708 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23858098 | ||
| Pubmed | [Expression of Zfx in mouse testicular spermatogenic cells]. | 5.90e-06 | 2 | 85 | 2 | 38602753 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20103595 | ||
| Pubmed | Interplay between ATM and ATR in the regulation of common fragile site stability. | 5.90e-06 | 2 | 85 | 2 | 17934520 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25483091 | ||
| Pubmed | ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. | 5.90e-06 | 2 | 85 | 2 | 23592994 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19527713 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12716983 | ||
| Pubmed | Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family. | 5.90e-06 | 2 | 85 | 2 | 9126493 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 39226322 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19071136 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12065055 | ||
| Pubmed | Evolution of the Zfx and Zfy genes: rates and interdependence between the genes. | 5.90e-06 | 2 | 85 | 2 | 8487630 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26567218 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17189255 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22972376 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26774662 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 33742106 | ||
| Pubmed | Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1. | 5.90e-06 | 2 | 85 | 2 | 11042216 | |
| Pubmed | Roles of ATM and ATR in DNA double strand breaks and replication stress. | 5.90e-06 | 2 | 85 | 2 | 33887296 | |
| Pubmed | ATR disruption leads to chromosomal fragmentation and early embryonic lethality. | 5.90e-06 | 2 | 85 | 2 | 10691732 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20530568 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18224251 | ||
| Pubmed | Zfx mutation results in small animal size and reduced germ cell number in male and female mice. | 5.90e-06 | 2 | 85 | 2 | 9187153 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31114877 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18996087 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35011623 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26517239 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 2265557 | ||
| Pubmed | DNA damage-sensing kinases mediate the mouse 2-cell embryo's response to genotoxic stress. | 5.90e-06 | 2 | 85 | 2 | 21593482 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25232030 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 36727301 | ||
| Pubmed | Development of the tight-skin phenotype in immune-deficient mice. | 5.90e-06 | 2 | 85 | 2 | 11263788 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8567125 | ||
| Pubmed | ATM acts downstream of ATR in the DNA damage response signaling of bystander cells. | 5.90e-06 | 2 | 85 | 2 | 18757420 | |
| Interaction | P2RY10 interactions | 2.73e-07 | 106 | 83 | 7 | int:P2RY10 | |
| Interaction | ZNF667-AS1 interactions | 6.70e-07 | 5 | 83 | 3 | int:ZNF667-AS1 | |
| Interaction | FAM234A interactions | 8.84e-07 | 126 | 83 | 7 | int:FAM234A | |
| Interaction | ZNF345 interactions | 2.33e-06 | 7 | 83 | 3 | int:ZNF345 | |
| Interaction | GPR17 interactions | 2.48e-06 | 283 | 83 | 9 | int:GPR17 | |
| Interaction | FPR1 interactions | 2.49e-06 | 147 | 83 | 7 | int:FPR1 | |
| Interaction | NPY2R interactions | 7.70e-06 | 66 | 83 | 5 | int:NPY2R | |
| Interaction | SPSB1 interactions | 9.99e-06 | 33 | 83 | 4 | int:SPSB1 | |
| Interaction | ATXN3L interactions | 1.09e-05 | 11 | 83 | 3 | int:ATXN3L | |
| Interaction | PLA2G2A interactions | 1.77e-05 | 38 | 83 | 4 | int:PLA2G2A | |
| Interaction | C8orf74 interactions | 1.87e-05 | 13 | 83 | 3 | int:C8orf74 | |
| Interaction | PLA2G4C interactions | 1.87e-05 | 13 | 83 | 3 | int:PLA2G4C | |
| Interaction | MRE11 interactions | 2.40e-05 | 287 | 83 | 8 | int:MRE11 | |
| Interaction | DCLRE1C interactions | 2.92e-05 | 43 | 83 | 4 | int:DCLRE1C | |
| Interaction | ELAPOR1 interactions | 3.63e-05 | 16 | 83 | 3 | int:ELAPOR1 | |
| Interaction | LIG4 interactions | 3.90e-05 | 152 | 83 | 6 | int:LIG4 | |
| Interaction | ZNF57 interactions | 4.39e-05 | 17 | 83 | 3 | int:ZNF57 | |
| Interaction | LINC00905 interactions | 5.01e-05 | 3 | 83 | 2 | int:LINC00905 | |
| Interaction | KIF5A interactions | 5.28e-05 | 98 | 83 | 5 | int:KIF5A | |
| Interaction | ITGB3 interactions | 7.28e-05 | 170 | 83 | 6 | int:ITGB3 | |
| Interaction | SPN interactions | 8.95e-05 | 57 | 83 | 4 | int:SPN | |
| Interaction | P2RY8 interactions | 9.67e-05 | 179 | 83 | 6 | int:P2RY8 | |
| Interaction | LINC01588 interactions | 9.80e-05 | 22 | 83 | 3 | int:LINC01588 | |
| Interaction | LINC00518 interactions | 1.00e-04 | 4 | 83 | 2 | int:LINC00518 | |
| Interaction | LYNX1 interactions | 1.00e-04 | 4 | 83 | 2 | int:LYNX1 | |
| Interaction | APOBEC4 interactions | 1.00e-04 | 4 | 83 | 2 | int:APOBEC4 | |
| Interaction | GOLGA2P5 interactions | 1.00e-04 | 4 | 83 | 2 | int:GOLGA2P5 | |
| Interaction | USP28 interactions | 1.04e-04 | 113 | 83 | 5 | int:USP28 | |
| Interaction | AZIN1 interactions | 1.12e-04 | 23 | 83 | 3 | int:AZIN1 | |
| Interaction | C3orf18 interactions | 1.13e-04 | 115 | 83 | 5 | int:C3orf18 | |
| Interaction | UCHL3 interactions | 1.16e-04 | 185 | 83 | 6 | int:UCHL3 | |
| Interaction | RANBP2 interactions | 1.20e-04 | 361 | 83 | 8 | int:RANBP2 | |
| Interaction | NTN5 interactions | 1.28e-04 | 24 | 83 | 3 | int:NTN5 | |
| Interaction | LMCD1 interactions | 1.28e-04 | 24 | 83 | 3 | int:LMCD1 | |
| Interaction | MSH5 interactions | 1.45e-04 | 25 | 83 | 3 | int:MSH5 | |
| Interaction | DRD4 interactions | 1.45e-04 | 25 | 83 | 3 | int:DRD4 | |
| Interaction | NPTN interactions | 1.50e-04 | 278 | 83 | 7 | int:NPTN | |
| Interaction | COPS5 interactions | TNPO1 RAF1 LRCH2 IARS1 UCHL3 UBR4 NCKIPSD APC RBM5 KIF5B PRKDC ATM SKA3 TP53BP1 | 1.51e-04 | 1102 | 83 | 14 | int:COPS5 |
| Interaction | HDAC1 interactions | SFMBT1 RAF1 KLF11 ATR KDM5C UBR4 BACH1 APC CDK5RAP2 ATM SKA3 CAMSAP1 CABIN1 KNL1 | 1.60e-04 | 1108 | 83 | 14 | int:HDAC1 |
| Interaction | LINC00663 interactions | 1.66e-04 | 5 | 83 | 2 | int:LINC00663 | |
| Interaction | SLC6A13 interactions | 1.66e-04 | 5 | 83 | 2 | int:SLC6A13 | |
| Interaction | KIAA0087 interactions | 1.66e-04 | 5 | 83 | 2 | int:KIAA0087 | |
| Interaction | GPR55 interactions | 1.68e-04 | 67 | 83 | 4 | int:GPR55 | |
| Interaction | CSNK1A1 interactions | 1.74e-04 | 381 | 83 | 8 | int:CSNK1A1 | |
| Interaction | CA14 interactions | 2.11e-04 | 71 | 83 | 4 | int:CA14 | |
| Interaction | BRCC3 interactions | 2.15e-04 | 132 | 83 | 5 | int:BRCC3 | |
| Interaction | OPALIN interactions | 2.25e-04 | 209 | 83 | 6 | int:OPALIN | |
| Interaction | FHL2 interactions | 2.26e-04 | 396 | 83 | 8 | int:FHL2 | |
| Interaction | MN1 interactions | 2.28e-04 | 29 | 83 | 3 | int:MN1 | |
| Interaction | HDAC4 interactions | PI4KA EFEMP2 UBR4 KCNMA1 APC KIF5B ATM CAMK1 TP53BP1 ZFX KIF3A | 2.31e-04 | 744 | 83 | 11 | int:HDAC4 |
| Interaction | EGLN3 interactions | TNPO1 RAF1 GBF1 LRCH2 PI4KA UBR4 BACH1 APC CDK5RAP2 PRR14L KIF5B PRKDC SKA3 CAMSAP1 KNL1 | 2.37e-04 | 1296 | 83 | 15 | int:EGLN3 |
| Interaction | GPR45 interactions | 2.39e-04 | 300 | 83 | 7 | int:GPR45 | |
| Interaction | DYNLL1 interactions | 2.48e-04 | 510 | 83 | 9 | int:DYNLL1 | |
| Interaction | MRPL20-AS1 interactions | 2.49e-04 | 6 | 83 | 2 | int:MRPL20-AS1 | |
| Interaction | RUSC1-AS1 interactions | 2.49e-04 | 6 | 83 | 2 | int:RUSC1-AS1 | |
| Interaction | CYP46A1 interactions | 2.49e-04 | 6 | 83 | 2 | int:CYP46A1 | |
| Interaction | USP5 interactions | 2.49e-04 | 213 | 83 | 6 | int:USP5 | |
| Interaction | BUB1 interactions | 2.56e-04 | 137 | 83 | 5 | int:BUB1 | |
| Interaction | YWHAZ interactions | RAF1 KLF11 ERBB3 GBF1 DSC2 NCKIPSD KCNMA1 APC CDK5RAP2 PRR14L KIF5B ATM KIF5C CAMSAP1 TP53BP1 | 2.87e-04 | 1319 | 83 | 15 | int:YWHAZ |
| Interaction | UPP1 interactions | 3.03e-04 | 78 | 83 | 4 | int:UPP1 | |
| Interaction | VSIG2 interactions | 3.07e-04 | 32 | 83 | 3 | int:VSIG2 | |
| Interaction | CD80 interactions | 3.18e-04 | 79 | 83 | 4 | int:CD80 | |
| Interaction | OPRM1 interactions | 3.22e-04 | 144 | 83 | 5 | int:OPRM1 | |
| Interaction | FAM174A interactions | 3.26e-04 | 224 | 83 | 6 | int:FAM174A | |
| Interaction | PRR30 interactions | 3.47e-04 | 7 | 83 | 2 | int:PRR30 | |
| Interaction | IL18RAP interactions | 3.47e-04 | 7 | 83 | 2 | int:IL18RAP | |
| Interaction | FMR1 interactions | 3.57e-04 | 536 | 83 | 9 | int:FMR1 | |
| Interaction | POU6F2 interactions | 3.66e-04 | 148 | 83 | 5 | int:POU6F2 | |
| Interaction | NDP interactions | 4.01e-04 | 35 | 83 | 3 | int:NDP | |
| Interaction | PHC2 interactions | 4.26e-04 | 153 | 83 | 5 | int:PHC2 | |
| Interaction | AP1B1 interactions | 4.40e-04 | 237 | 83 | 6 | int:AP1B1 | |
| Interaction | HLA-B interactions | 4.60e-04 | 239 | 83 | 6 | int:HLA-B | |
| Interaction | SLFN12 interactions | 4.62e-04 | 8 | 83 | 2 | int:SLFN12 | |
| Interaction | ERAS interactions | 4.62e-04 | 8 | 83 | 2 | int:ERAS | |
| Interaction | OGFOD2 interactions | 4.62e-04 | 8 | 83 | 2 | int:OGFOD2 | |
| Interaction | NSUN7 interactions | 4.62e-04 | 8 | 83 | 2 | int:NSUN7 | |
| Interaction | CENPK interactions | 4.79e-04 | 88 | 83 | 4 | int:CENPK | |
| Interaction | SASS6 interactions | 5.08e-04 | 159 | 83 | 5 | int:SASS6 | |
| Interaction | CREM interactions | 5.22e-04 | 90 | 83 | 4 | int:CREM | |
| Interaction | PELO interactions | 5.37e-04 | 161 | 83 | 5 | int:PELO | |
| Interaction | BRCA1 interactions | TNPO1 GBF1 ATR IARS1 UBR4 XAF1 KIF5B PRKDC ATM CABIN1 TP53BP1 TRIM74 KNL1 FANCA | 5.43e-04 | 1249 | 83 | 14 | int:BRCA1 |
| Interaction | YWHAH interactions | RAF1 GBF1 LRCH2 DSC2 TFB1M PI4KA NCKIPSD KCNMA1 APC KIF5B KIF5C SKA3 CAMSAP1 | 5.43e-04 | 1102 | 83 | 13 | int:YWHAH |
| Interaction | RHEB interactions | 5.84e-04 | 164 | 83 | 5 | int:RHEB | |
| Interaction | APLN interactions | 5.92e-04 | 9 | 83 | 2 | int:APLN | |
| Interaction | DAPL1 interactions | 5.92e-04 | 9 | 83 | 2 | int:DAPL1 | |
| Interaction | MAGEC3 interactions | 5.92e-04 | 9 | 83 | 2 | int:MAGEC3 | |
| Interaction | CHRM4 interactions | 6.15e-04 | 94 | 83 | 4 | int:CHRM4 | |
| Interaction | FXYD3 interactions | 6.15e-04 | 94 | 83 | 4 | int:FXYD3 | |
| Interaction | DOCK7 interactions | 6.34e-04 | 254 | 83 | 6 | int:DOCK7 | |
| Interaction | NOSIP interactions | 6.40e-04 | 95 | 83 | 4 | int:NOSIP | |
| Interaction | ATRIP interactions | 6.40e-04 | 95 | 83 | 4 | int:ATRIP | |
| Interaction | INSYN1 interactions | 6.70e-04 | 169 | 83 | 5 | int:INSYN1 | |
| Interaction | SHFL interactions | 6.93e-04 | 97 | 83 | 4 | int:SHFL | |
| Interaction | KCNMB1 interactions | 7.38e-04 | 10 | 83 | 2 | int:KCNMB1 | |
| Interaction | GYPA interactions | 7.64e-04 | 174 | 83 | 5 | int:GYPA | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.22e-05 | 95 | 57 | 5 | 59 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 2.03e-04 | 7 | 57 | 2 | 785 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.10e-04 | 46 | 57 | 3 | 622 | |
| GeneFamily | Ring finger proteins | 1.72e-03 | 275 | 57 | 5 | 58 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TNPO1 ZBTB38 ATR IARS1 PENK APC TRIM63 CDK5RAP2 KIF5B ZNF85 ATM KIF3A KNL1 | 1.90e-07 | 656 | 85 | 13 | M18979 |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 9.63e-07 | 101 | 85 | 6 | M15356 | |
| Coexpression | VALK_AML_CLUSTER_6 | 4.43e-06 | 34 | 85 | 4 | M4965 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | ZBTB38 ATR SP140L IARS1 KCNMA1 APC XAF1 KIF5B SKA3 CAMSAP1 KNL1 | 2.12e-05 | 721 | 85 | 11 | M10237 |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN | 4.85e-05 | 200 | 85 | 6 | M5153 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 175 | 85 | 6 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-06 | 185 | 85 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-06 | 187 | 85 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.36e-06 | 144 | 85 | 5 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-05 | 154 | 85 | 5 | f29316d4b4dcdb23bd427d78068e65a9802f7f07 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-05 | 154 | 85 | 5 | 66065c0763c83d98084ca6969694c3af37e43274 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 155 | 85 | 5 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 158 | 85 | 5 | 2ef43d14ee65d004dc62c12ff209bbe12e4db681 | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.35e-05 | 159 | 85 | 5 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-05 | 172 | 85 | 5 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 180 | 85 | 5 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 180 | 85 | 5 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.80e-05 | 185 | 85 | 5 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.87e-05 | 186 | 85 | 5 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-05 | 187 | 85 | 5 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 187 | 85 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 187 | 85 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 187 | 85 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 3.02e-05 | 188 | 85 | 5 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 189 | 85 | 5 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.10e-05 | 189 | 85 | 5 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | 2abeb013bb83c578e67dcb985ba44ca63134950b | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.18e-05 | 190 | 85 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.26e-05 | 191 | 85 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 191 | 85 | 5 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.42e-05 | 193 | 85 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.51e-05 | 194 | 85 | 5 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 194 | 85 | 5 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-05 | 195 | 85 | 5 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-05 | 196 | 85 | 5 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.69e-05 | 196 | 85 | 5 | 1cc2b11764584129703ec61965e8ec4e051464e7 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-05 | 196 | 85 | 5 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.69e-05 | 196 | 85 | 5 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 197 | 85 | 5 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.87e-05 | 198 | 85 | 5 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-05 | 199 | 85 | 5 | 08bdcabc3fce787578a8eb66fc8412b0974fa6cc | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | 11.5-Airway|11.5 / Age, Tissue, Lineage and Cell class | 4.06e-05 | 200 | 85 | 5 | 9e3a8978b76ee9ba1ccc220f128dad081eceba1a | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.06e-05 | 200 | 85 | 5 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-05 | 200 | 85 | 5 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Sigmoid-ILC|Sigmoid / Region, Cell class and subclass | 4.06e-05 | 200 | 85 | 5 | dfb06821f1019833f5d81f9c93808219b5fef407 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-05 | 200 | 85 | 5 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Sigmoid-(3)_ILC|Sigmoid / shred on region, Cell_type, and subtype | 4.06e-05 | 200 | 85 | 5 | a7326c43987a5eb4f4f5b48c4252cf4870432e5d | |
| ToppCell | Sigmoid-(3)_ILC-(30)_ILC|Sigmoid / shred on region, Cell_type, and subtype | 4.06e-05 | 200 | 85 | 5 | c39de94623383da7b2b260eb016ddaa5da7f4350 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-05 | 200 | 85 | 5 | a603e8a999612d523bbce9d0feca9296d4a24c97 | |
| ToppCell | Sigmoid-ILC-ILC|Sigmoid / Region, Cell class and subclass | 4.06e-05 | 200 | 85 | 5 | 4ac1e6d7f358003e2448eb69e545772cd261c55f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-05 | 200 | 85 | 5 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-05 | 200 | 85 | 5 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-04 | 130 | 85 | 4 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | ASK452-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-04 | 132 | 85 | 4 | 49ba24e24b3127b5257a88a0ee0246c9843c580a | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 139 | 85 | 4 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 142 | 85 | 4 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.67e-04 | 144 | 85 | 4 | 7de962346ba9653d90dd13bb7d977fe44d200bba | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 148 | 85 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 150 | 85 | 4 | 6e806a028c0519489151c181d9907e05289e27e0 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-04 | 150 | 85 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.05e-04 | 152 | 85 | 4 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-04 | 154 | 85 | 4 | ec56b7fb88e39041416c384f371c767f3b4e92fa | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-04 | 154 | 85 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 154 | 85 | 4 | 66c93733116e31b65dfb4b0b00de5c39d19cdb84 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-04 | 154 | 85 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 2.21e-04 | 155 | 85 | 4 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.21e-04 | 155 | 85 | 4 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.26e-04 | 156 | 85 | 4 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 157 | 85 | 4 | b527e88382c8d21188a0f222b3302523e8816dfc | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.38e-04 | 158 | 85 | 4 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 161 | 85 | 4 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-04 | 164 | 85 | 4 | ae09e5aabd1347b865474255e7411c04f63efb3b | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.87e-04 | 166 | 85 | 4 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-04 | 167 | 85 | 4 | 0aa1973141a2437df24c9857cd50ff3dfc7673c0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-04 | 168 | 85 | 4 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like|Lung / Manually curated celltypes from each tissue | 3.00e-04 | 168 | 85 | 4 | b9bde6f542d730682d34a80e1f7f1609e5c699c7 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.00e-04 | 168 | 85 | 4 | a8958b94ffc3423d56c250796dd253884b46f9d9 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-04 | 169 | 85 | 4 | 02fa66a91b8bd2bf971aec4f5ec58318b5bfdf14 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-04 | 169 | 85 | 4 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.07e-04 | 169 | 85 | 4 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 3.14e-04 | 170 | 85 | 4 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.14e-04 | 170 | 85 | 4 | aaf29c2d4de172d366cbfc863bc741941667dde1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 171 | 85 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 171 | 85 | 4 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 171 | 85 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.21e-04 | 171 | 85 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.25e-04 | 70 | 85 | 3 | 8d6bdf2e773e894a0db39fdff1fafc2474e03fcf | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 172 | 85 | 4 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | URO-Lymphocyte-B-Plasmablast|URO / Disease, Lineage and Cell Type | 3.28e-04 | 172 | 85 | 4 | 48888ef50ac784b38aca81da68f8a94ce09c670d | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 172 | 85 | 4 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 173 | 85 | 4 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 3.35e-04 | 173 | 85 | 4 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | 15af4a0f7516dbf5c93ba66a19aca073ebe30d04 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 173 | 85 | 4 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 173 | 85 | 4 | 2cba41c3d9d3076f703115d19729073a3ac3feb6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 173 | 85 | 4 | 11d69a4ab4a87b8820cd3bd204de8c4124450a90 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 174 | 85 | 4 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-04 | 174 | 85 | 4 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 174 | 85 | 4 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | droplet-Heart-4Chambers-21m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 174 | 85 | 4 | f098778ea74012861ec74b425e45776a31f67679 | |
| Drug | Digoxin [20830-75-5]; Down 200; 5.2uM; PC3; HT_HG-U133A | 6.35e-06 | 191 | 83 | 7 | 6724_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 6.35e-06 | 191 | 83 | 7 | 5214_DN | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 6.80e-06 | 193 | 83 | 7 | 5315_UP | |
| Drug | 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one | 7.00e-06 | 34 | 83 | 4 | ctd:C569670 | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 7.52e-06 | 196 | 83 | 7 | 7027_DN | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 8.03e-06 | 198 | 83 | 7 | 6326_UP | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 8.30e-06 | 199 | 83 | 7 | 5045_DN | |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 8.58e-06 | 200 | 83 | 7 | 3438_DN | |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; HL60; HT_HG-U133A | 8.58e-06 | 200 | 83 | 7 | 2385_DN | |
| Drug | Aphidicolin | 3.06e-05 | 17 | 83 | 3 | ctd:D016590 | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 3.26e-05 | 166 | 83 | 6 | 3283_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.66e-05 | 177 | 83 | 6 | 6340_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 7.54e-05 | 193 | 83 | 6 | 4286_DN | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 7.54e-05 | 193 | 83 | 6 | 3296_UP | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 7.75e-05 | 194 | 83 | 6 | 1670_DN | |
| Drug | Methoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 7.75e-05 | 194 | 83 | 6 | 3302_UP | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 7.75e-05 | 194 | 83 | 6 | 4387_DN | |
| Drug | D-alanyl-D-lactate | 7.84e-05 | 4 | 83 | 2 | CID005487001 | |
| Drug | lolitrem B | 7.84e-05 | 4 | 83 | 2 | CID003086140 | |
| Drug | AC1L2JQN | 7.84e-05 | 4 | 83 | 2 | CID000022092 | |
| Drug | NSC-85245 | 7.85e-05 | 23 | 83 | 3 | CID000257281 | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 7539_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 5109_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 4398_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 3271_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; HL60; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 1841_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2329_DN | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 6309_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2119_DN | |
| Drug | 3-hydroxy-3-methylglutaric acid | 8.30e-05 | 63 | 83 | 4 | CID000001662 | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 7130_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 4608_DN | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 5447_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 2068_DN | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 4783_UP | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 4977_UP | |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; PC3; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 2100_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 3333_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.17e-05 | 200 | 83 | 6 | 3425_UP | |
| Disease | Benign neoplasm of stomach | 1.35e-07 | 17 | 83 | 4 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.35e-07 | 17 | 83 | 4 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.35e-07 | 17 | 83 | 4 | C0154060 | |
| Disease | Stomach Carcinoma | 3.36e-07 | 21 | 83 | 4 | C0699791 | |
| Disease | endometrial cancer (is_implicated_in) | 3.20e-06 | 36 | 83 | 4 | DOID:1380 (is_implicated_in) | |
| Disease | Glioma | 4.81e-06 | 87 | 83 | 5 | C0017638 | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 7.82e-06 | 2 | 83 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | aortic aneurysm (is_implicated_in) | 2.34e-05 | 3 | 83 | 2 | DOID:3627 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 5.91e-05 | 616 | 83 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.91e-05 | 616 | 83 | 9 | C0376358 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.29e-04 | 195 | 83 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_marker_for) | 2.44e-04 | 43 | 83 | 3 | DOID:9261 (is_marker_for) | |
| Disease | asthma | 2.62e-04 | 751 | 83 | 9 | MONDO_0004979 | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 2.78e-04 | 9 | 83 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | pancreatic cancer (is_implicated_in) | 2.87e-04 | 112 | 83 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Adenocarcinoma of lung (disorder) | 2.95e-04 | 206 | 83 | 5 | C0152013 | |
| Disease | colorectal cancer (is_implicated_in) | 3.85e-04 | 121 | 83 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | colon cancer (implicated_via_orthology) | 4.23e-04 | 11 | 83 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Malignant Neoplasms | 4.76e-04 | 128 | 83 | 4 | C0006826 | |
| Disease | motor neuron disease (implicated_via_orthology) | 5.07e-04 | 12 | 83 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | gallbladder cancer (is_implicated_in) | 5.98e-04 | 13 | 83 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 6.23e-04 | 59 | 83 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 6.54e-04 | 60 | 83 | 3 | C4722327 | |
| Disease | melanoma | 6.86e-04 | 248 | 83 | 5 | C0025202 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 8.02e-04 | 15 | 83 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 8.02e-04 | 15 | 83 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 8.02e-04 | 15 | 83 | 2 | C0154091 | |
| Disease | Autosomal recessive primary microcephaly | 8.02e-04 | 15 | 83 | 2 | cv:C3711387 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 8.21e-04 | 148 | 83 | 4 | C0279702 | |
| Disease | Colonic Neoplasms | 9.07e-04 | 152 | 83 | 4 | C0009375 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 9.14e-04 | 16 | 83 | 2 | C0334634 | |
| Disease | Prostate cancer, familial | 9.84e-04 | 69 | 83 | 3 | C2931456 | |
| Disease | Non-Small Cell Lung Carcinoma | 9.99e-04 | 156 | 83 | 4 | C0007131 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.07e-03 | 71 | 83 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Malignant tumor of colon | 1.07e-03 | 159 | 83 | 4 | C0007102 | |
| Disease | monocyte count | TNPO1 THADA PLVAP PIK3CD GLG1 PI4KA EFEMP2 PRKDC ATM CABIN1 FANCA | 1.16e-03 | 1320 | 83 | 11 | EFO_0005091 |
| Disease | nucleotide measurement | 1.16e-03 | 73 | 83 | 3 | EFO_0010513 | |
| Disease | Carcinoma of bladder | 1.16e-03 | 18 | 83 | 2 | C0699885 | |
| Disease | ovulation | 1.30e-03 | 19 | 83 | 2 | GO_0030728 | |
| Disease | receptive language perception | 1.30e-03 | 19 | 83 | 2 | EFO_0005686 | |
| Disease | Adenocarcinoma of prostate | 1.44e-03 | 20 | 83 | 2 | C0007112 | |
| Disease | Stomach Neoplasms | 1.53e-03 | 297 | 83 | 5 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.60e-03 | 300 | 83 | 5 | C0024623 | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.74e-03 | 22 | 83 | 2 | C3711387 | |
| Disease | Primary microcephaly | 1.74e-03 | 22 | 83 | 2 | C0431350 | |
| Disease | refractive error, age at onset, Myopia | 2.18e-03 | 193 | 83 | 4 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | nevus count, cutaneous melanoma | 2.18e-03 | 91 | 83 | 3 | EFO_0000389, EFO_0004632 | |
| Disease | breast cancer (implicated_via_orthology) | 2.25e-03 | 25 | 83 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | refractive error | 2.29e-03 | 326 | 83 | 5 | MONDO_0004892 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.43e-03 | 26 | 83 | 2 | C0009405 | |
| Disease | Endogenous Hyperinsulinism | 2.43e-03 | 26 | 83 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 2.43e-03 | 26 | 83 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 2.43e-03 | 26 | 83 | 2 | C1257965 | |
| Disease | Adenocarcinoma of large intestine | 2.54e-03 | 96 | 83 | 3 | C1319315 | |
| Disease | lymphocyte count | TNPO1 ERBB3 THADA ZBTB38 FBN1 GBF1 PIK3CD DEF6 ATM IL18RAP KNL1 | 2.62e-03 | 1464 | 83 | 11 | EFO_0004587 |
| Disease | Bone Diseases, Developmental | 2.62e-03 | 27 | 83 | 2 | C0005941 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 2.62e-03 | 27 | 83 | 2 | DOID:0050861 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EARECENMFPKKSCA | 396 | F5H4B4 | |
| CVRACPPDKMEVDKN | 301 | P21860 | |
| GVPECRDLQVMLKCD | 266 | O14867 | |
| SKDPGKLIEMECLEC | 321 | Q8IYW2 | |
| LEDNMLCPKCVHRNK | 281 | Q7L190 | |
| DFVKMCLEANIPLEK | 106 | Q9UFW8 | |
| CRPKKDMCDLEEFCD | 466 | P78325 | |
| INRCVALKLCDFEMP | 396 | A1A5B4 | |
| YCPEQMKLDDICLKE | 261 | Q5T5Y3 | |
| NLEPKFRTLAEACMK | 886 | Q02487 | |
| LIQCLKEEKSQMACP | 236 | Q96SN8 | |
| NCPKAMKRLVADCVK | 576 | P04049 | |
| DCLCQMLDLVKPRTE | 436 | Q9Y5P8 | |
| ECNIKVMCRFRPLNE | 6 | P33176 | |
| LACVMECEGKLPSLK | 46 | P01210 | |
| LMDEPLLCKEREVAC | 131 | Q8IYW4 | |
| DVACCVKMILEVKPQ | 136 | O95256 | |
| NKKCIPMDLQCDRLD | 3771 | Q9NZR2 | |
| PTVCELCFVKLKLLM | 616 | Q12791 | |
| MKRIFEPKCLDAFLN | 166 | P46439 | |
| LRMDPKCSFVEKERQ | 526 | Q9NQS7 | |
| MKLLPVDCERKTDEF | 246 | Q8NC56 | |
| LVEKMERCNPLFMRC | 1781 | Q9UKN7 | |
| QKKVPDNCCRREPML | 361 | P04035 | |
| LDMKDQSCKPCAEGR | 101 | Q6UXG2 | |
| VQALCLPLDKDKFEM | 221 | Q9BX97 | |
| RLCIGECKPEFMTKS | 931 | O75051 | |
| RPASLEKVQKLLCMC | 46 | P42356 | |
| EKVQKLLCMCPVDFH | 51 | P42356 | |
| MLLCDKDEEKANYCP | 1346 | Q8NG31 | |
| DLDMCPLYKLQKTEC | 191 | Q6PEW0 | |
| CRPLNEREKSMCYKQ | 21 | Q9Y496 | |
| KMACLLCRRQFPNKD | 646 | P52756 | |
| TNCVPAIMEKKDCPR | 216 | Q8IZP7 | |
| LMEKDPEKRFTCEQA | 256 | Q14012 | |
| KMACKEDVLKLCPNI | 756 | Q92896 | |
| CEILQLLKPMCEVKT | 1821 | Q13315 | |
| LLKPMCEVKTDFCQT | 1826 | Q13315 | |
| AKENECMRIKILGDC | 326 | Q08462 | |
| CKPKDDLRKDCRLME | 2326 | Q13535 | |
| PCLRKDSLRMFLKCD | 206 | Q9Y6J0 | |
| FKDINECKMIPSLCT | 1026 | P35555 | |
| MVDFILAKCQTKCPL | 1151 | O15360 | |
| IMVCEKDPALKNRCH | 151 | P26992 | |
| KQENGRKEMPICCII | 706 | Q3MJ40 | |
| VMKQKLCEESVCPTR | 206 | Q96P44 | |
| LPDRDGKRCMFCVKT | 271 | Q9H4E7 | |
| VALECIKQCDPEKMI | 1106 | Q92538 | |
| EKKFVCPVCDRRFMR | 451 | O14901 | |
| NECLTIPEACKGEMK | 56 | O95967 | |
| FMLQPDRKTCKDIDE | 266 | Q8IX30 | |
| LNIQACCRMDKKPDS | 301 | Q5VUJ6 | |
| VCRSLKDCEMEKCPD | 1136 | Q5THK1 | |
| CNPAEKKIFMARCDP | 561 | Q49A17 | |
| MKENHPECFCKILKI | 1596 | Q6YHU6 | |
| PECFCKILKILHCMD | 1601 | Q6YHU6 | |
| ECSIKVMCRFRPLNE | 6 | O60282 | |
| AMSKKCPICRVDIET | 326 | Q6ZSG1 | |
| ARNPDMNKCIKCKIE | 86 | Q2MKA7 | |
| LKVLCMPAEEFRELK | 371 | Q8TBK2 | |
| PTKQLLPCEMACNEK | 276 | Q9NR45 | |
| LPCEMACNEKLGKSV | 281 | Q9NR45 | |
| KSLCDVYRKMCDEDP | 301 | Q8WVM0 | |
| CMDFNIIRKDSLPVC | 336 | P41252 | |
| RQMCPEEQLKCEFLL | 466 | Q9H930 | |
| LTDADPEVCKKMCKR | 421 | Q9NZQ3 | |
| PEVCKKMCKRNEFES | 426 | Q9NZQ3 | |
| ICPAVCVLMKLSFDE | 446 | P25054 | |
| NLEKQLICPICLEMF | 16 | Q969Q1 | |
| CALKMDDFECVTPKL | 206 | Q8IX90 | |
| CPICLEVFKESLMLQ | 16 | Q86UV6 | |
| EKQLICPICLEMFSK | 21 | Q9BYV2 | |
| IEVCKKFMERDPDEL | 206 | P15374 | |
| EKQLICPICLEMFTK | 21 | Q9BYV6 | |
| PKASMVVKDCVRACL | 1536 | Q8NB66 | |
| LQLRKGCESVDECKM | 111 | P0DPD5 | |
| ERPVECKFCKLDMQL | 81 | Q6GPH4 | |
| LCDPEVNDFRAKMCQ | 131 | O00329 | |
| LCLQKEMPKKECSEA | 701 | Q12888 | |
| INPKDDLRDMFCKIL | 851 | Q92973 | |
| PKMQLVCCRAIVKVF | 451 | P78527 | |
| PECKDCHRKFMDVSQ | 406 | O43167 | |
| SMEKCLQDFCLPFLR | 1641 | Q6ZT12 | |
| KEMPFKCDICLLTFS | 601 | P17010 | |
| CPICLEVFKESLMLQ | 16 | Q86UV7 | |
| NLPLRKGCESMDECK | 111 | Q03923 | |
| QECMDLKLGPAIKLC | 836 | Q9UHJ3 | |
| TKEMPKLQCELCDGD | 976 | Q8NAP3 | |
| EKPFECDICDMRFIQ | 126 | Q8NDX6 | |
| PLMRDIKNKICQDCD | 4381 | Q5T4S7 | |
| SKEMPFKCDICLLTF | 596 | P08048 | |
| ELICKMAACPEKLDL | 646 | P41229 |